Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 16, 2025
Genomic Characteristics Related to Histology-Based Immune Features in Breast CancerYoon Jin Cha, Constandina E O'Connell, Benjamin C Calhoun, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 1, 2025
Identifying locally recurrent versus second primary breast cancer: Genomic versus clinical criteria from Carolina Breast Cancer Study Phase IIISarah C Van Alsten, Michael I Love, Benjamin C Calhoun, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 19, 2022
The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer PatientsAlina M Hamilton, Amber N Hurson, Linnea T Olsson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 24, 2021
Protein-based immune profiles of basal-like vs. luminal breast cancersAndrea Walens, Linnea T Olsson, Xiaohua Gao, et al.
The Breast Journal|November 19, 2018
Cystic neutrophilic granulomatous mastitis: The Cleveland Clinic experience with diagnosis and managementIla Gautham, Diane M Radford, Christopher S Kovacs, et al.
JNCI Cancer Spectrum|January 14, 2021
Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological FeaturesHalei C Benefield, Katherine E Reeder-Hayes, Hazel B Nichols, et al.
The Journal of Clinical Investigation|March 4, 2010
Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomasKi Taek Nam, Hyuk-Joon Lee, J Joshua Smith, et al.
Nature Communications|February 10, 2018
Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinasePraveena S Thiagarajan, Maksim Sinyuk, Soumya M Turaga, et al.
Journal for Immunotherapy of Cancer|February 5, 2022
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancerCarey K Anders, Mark G Woodcock, Amanda E D Van Swearingen, et al.
Pageof 6